Dr. Kinder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Eastowne Dr
Chapel Hill, NC 27514Phone+1 984-974-5703
Summary
- Dr. Brent Kinder is a pulmonologist based in Chapel Hill, NC, with subspecialties in Critical Care Medicine and Pulmonary Disease. He completed his residency in Internal Medicine at the University of California, San Francisco, and graduated from Emory University School of Medicine in 2000. Currently, he serves as an Associate Professor at the University of North Carolina, Chapel Hill Hospitals, focusing on conditions such as interstitial lung disease, Lymphangioleiomyomatosis, and Idiopathic Pulmonary Fibrosis. Dr. Kinder has many publications, including highly-cited articles on Lymphangioleiomyomatosis and NSIP in the New England Journal of Medicine and the American Journal of Respiratory and Critical Care Medicine. He has participated in clinical trials related to idiopathic pulmonary fibrosis and lymphangioleiomyomatosis. He received the CMS Meaningful Use Stage 1 Certification for his work with EpicCare Ambulatory EMR from Epic Systems Corporation.
Education & Training
- University of California (San Francisco)Residency, Internal Medicine, 2000 - 2003
- Emory University School of MedicineClass of 2000
Certifications & Licensure
- CA State Medical License 2002 - Present
- NC State Medical License 2021 - 2026
- OH State Medical License 2007 - 2026
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Efficacy and Safety of Sirolimus in LAM Start of enrollment: 2006 Dec 01
- Losartan in Treating Patients With Idiopathic Pulmonary Fibrosis Start of enrollment: 2009 Mar 01
Publications & Presentations
PubMed
- 184 citationsOfficial American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and ManagementFrancis X. McCormack, Nishant Gupta, Geraldine R. Finlay, Lisa R. Young, Angelo M. Taveira-Da Silva
American Journal of Respiratory and Critical Care Medicine. 2016-09-15 - 40 citationsTreatment of Idiopathic Pulmonary Fibrosis with Losartan: A Pilot ProjectMarisa Couluris, Brent W. Kinder, Ping Xu, Margaret Gross-King, Jeffrey P. Krischer
Lung. 2012-07-19 - 6 citationsNonspecific interstitial pneumonia.Brent Wayne Kinder
Clinics in Chest Medicine. 2012-03-01
Grant Support
- Undifferentiated Connective Tissue-Associated Interstitial Lung Disease CohortNational Heart, Lung, And Blood Institute2010–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: